Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
Predrag Sikiric at the University of Zagreb, where the gastric body protection compound was first isolated
This treatment ensures efficient nutrient absorption and assists in improving red blood cell production, supporting energy levels and overall health
At the cellular level, BPC-157 increases the formation of new blood vessels (angiogenesis), which delivers more oxygen and nutrients to injured tissues
Your Journey Our medical team guides you through every step of your multi-peptide healing journey
[9] Using retatrutide outside of an approved, ethics-committee-reviewed clinical trial carries significant risks, as research-grade peptides are not subject to the same manufacturing standards, purity controls, or safety oversight as licensed medicines
US$ 28.32
US$ 21.83
US$ 22.27
US$ 26.99
US$ 26.81
US$ 26.67
